Developments Fibrocor, Galapagos NV in development pact for fibrotic diseases Closely-held Fibrocor Therapeutics, and Galapagos NV (Euronext, NASDAQ:GLPG), of Belgium formed a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs. In 2017, MaRs... January 8, 2019